Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that the board of directors of the Company has declared a cash dividend for the second quarter of 2017 of $0.08 per common share, or approximately $3 million in the aggregate. This dividend is the first declared by the Company since its initial public offering, which closed on July 7, 2017. The dividend will be paid on September 15, 2017 to all common shareholders of record at the close of business on September 1, 2017. The Company has designated this dividend as an “eligible dividend” for the purposes of the Income Tax Act (Canada).... more
Novartis AG (NVS) is yet another dividend star in the pharma sector and has a long history of over 16 years of regular dividend payment. The stock is currently trading at its 52 weeks high of $86.90 and even at this high price point, Novartis gives an impressive dividend yield of 3.28 percent. The stock had a slow start this year but started showing momentum in the second quarter. Since then the stock has given impressive returns. With its strong fundamentals and attractive dividend yield, the stock is a must-have for a medium to long term portfolio.
The company recently reported its second quarter financial figures, which provided an interesting insight into the workings and the likely future direction for the company. Overall, the company announced better than expected figures,... more
Roche (OTCQX: RHHBY) is one of the top performers in the pharma sector when it comes to offering strong dividend performance. The company has a track record of delivering regular dividend as well as of steady growth rate. While the stock price is flat on trailing twelve months basis, it is likely to show strong performance as the company launched a bunch of promising new drugs earlier this year. Roche, thus offers capital appreciation combined with attractive dividend yield, making it an ideal pick for investors with a long term investment horizon.
The company recently revised its full year outlook on the strength of its new drug launches earlier this year. Roche classifies its business into two main categories which are Pharmaceuticals and Diagnostics. Both the units showed 5 percent... more
Pfizer Inc. (NYSE: PFE) stock comes with a rather formidable dividend yield of 3.92 percent, which, coupled with a strong growth rate, makes it one of the dividend superstars in the pharma sector. The stock currently trades almost midway between its 52 weeks low and high of $29.83 and $35.38 respectively and thus offers a good point to build a position. The company recently reported rather tepid quarterly numbers but made up for those with a few product approvals. Management's decision to raise EPS guidance is also a sign of good things to come.
The company boosted its position in the oncology market as the FDA granted its approval to Besponsa for treating a form of blood cancer. The drug may now be used as a monotherapy for the treatment of relapsed or refractory CD22-positive... more
Caterpillar Inc. (CAT) comes with an impressive track record of dividend growth. The world's largest construction and mining equipment maker has paid higher dividends for 23 consecutive years. However, the company, which has struggled with declining sales in the last few years, hasn't made a meaningful increase in dividends since early-2015. But now, I believe that Caterpillar looks well positioned to significantly grow dividends from the first half of 2018.
Caterpillar has been struggling with shrinking revenues, earnings and cash flows, thanks to the weakness in commodity prices that has suppressed equipment demand. Last year, for instance, the company's sales plunged, for the fourth time in a row, by 18% to $38.54 billion. The company's adjusted profits... more
Subscribers ofThe Mortgage REIT Forum had early access to this article over the weekend and received real-time text message alerts.
Ladies and gentlemen,
I present to you the preferred share that competes with Annaly Capital Management’s (NLY) NLY-F.
AGNC Investment Corp. (AGNC) has a new preferred share in my buy range. Last month I warned investors that AGNCP had a material amount of call risk. The total value of preferred shares outstanding was not that high compared to the amount of common equity of AGNC Investment Corp. I believed that it wouldn’t be difficult for AGNC to issue a new preferred share and call AGNCP. AGNCP has now been called, and the new preferred share, AGNNP, is attractive for investors. The company was able to call their shares... more
STORE Capital Corporation (STOR) is in a strong financial position to grow its dividend payout. Further, the stock sale to a subsidiary of Berkshire Hathaway in the second quarter instantly caused the REIT to gain credibility as a quality income vehicle. STORE Capital has consistently had top-notch portfolio and dividend coverage stats, and I continue to see STORE Capital has a promising bet on long term dividend growth.
STORE Capital’s shares surged in the second quarter after the real estate investment trust sold shares to a subsidiary of Warren Buffett’s investment vehicle, Berkshire Hathaway. The sale immediately created higher visibility for STORE Capital, and put the REIT at the top of income investors’ shopping lists. Though shares have surged lately from $20... more
Control4 Corp (CTRL) appears to be a controversial stock. The bulls like it because of leverage to secular growth in the home automation market. The bears believe it’s about to be disrupted by Amazon (AMZN) and Google (GOOG) (Nasdaq: GOOGL), among others, with their popular do-it-yourself devices/connectivity, and it seems every week these companies are introducing new features to make their consumer appeal stronger, all at much lower price points (and without Control4's dealer installation). However, this article is not going to address either of the bull/bear debates, but rather focus on analytical and valuation errors by sell-side analysts around the company’s NOL, which I estimate overstates consensus EPS estimates, and in turn, target prices, by ~30%, all else equal.... more
Rig counts have risen sharply in 2017. It seemed, after a long and painful downturn, the oil industry was finally on the road to recovery. But oil prices have not been able to climb above $50 per barrel and stay there for any length of time, which has taken down oilfield services stocks as a result.
For example, Helmerich & Payne (HP) has lost 44% of its value year to date. Revenue has increased significantly so far in 2017, but the company continues to lose money. Analysts have even called into question whether the dividend is sustainable.
Due to its plunging share price, HP’s dividend yield has risen to 6.5%. HP is one of 400 stocks with a 5%+ dividend yield.
And, HP has a long history of dividend growth. It is a Dividend Achiever, which have raised dividends for... more
BHP Billiton (BHP) (OTCPK: BHPLF) (OTCPK: BHPBF) (BBL) is the world's biggest mining company, and it is being positioned for the future by the company's management team. A cleaner balance sheet, a focus on cost cutting and higher capital returns, as well as very strong cash flows provide a good outlook for the company's shares in the long run.
As a mining company BHP Billiton is active in a quite cyclical industry, which sees steep ups and downs:
BHP Net Income (NYSE: TTM) data by YChartsWith big swings in the company's profitability, it is not surprising that BHP Billiton's share price is moving quite a lot as well, moving in a range between $20 and $95 over the last decade:
BHP data by YChartsWith its most recent results, which the company announced... more